Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
China Life Insurance Co ( (HK:2628) ) has provided an update.
China Life Insurance Company Limited announced that its gross written premiums have exceeded RMB700 billion as of November 30, 2025. This significant achievement reflects the company’s robust performance and its strong market position in the Chinese insurance industry, indicating positive implications for its stakeholders and future growth prospects.
The most recent analyst rating on (HK:2628) stock is a Buy with a HK$32.00 price target. To see the full list of analyst forecasts on China Life Insurance Co stock, see the HK:2628 Stock Forecast page.
More about China Life Insurance Co
China Life Insurance Company Limited is a leading insurance provider in China, primarily offering life insurance products and services. The company focuses on providing comprehensive insurance solutions to individuals and businesses, maintaining a strong presence in the Chinese insurance market.
Average Trading Volume: 64,485,701
Technical Sentiment Signal: Buy
Current Market Cap: HK$1250.9B
See more insights into 2628 stock on TipRanks’ Stock Analysis page.